Your browser doesn't support javascript.
loading
Telemedicine Applications for Cancer Rehabilitation: Scoping Review.
Goncalves Leite Rocco, Patricia; Reategui-Rivera, C Mahony; Finkelstein, Joseph.
Affiliation
  • Goncalves Leite Rocco P; Department of Biomedical Informatics, School of Medicine, University of Utah, Salt Lake City, UT, United States.
  • Reategui-Rivera CM; Department of Biomedical Informatics, School of Medicine, University of Utah, Salt Lake City, UT, United States.
  • Finkelstein J; Department of Biomedical Informatics, School of Medicine, University of Utah, Salt Lake City, UT, United States.
JMIR Cancer ; 10: e56969, 2024 Aug 21.
Article in En | MEDLINE | ID: mdl-39079103
ABSTRACT

BACKGROUND:

Cancer is a significant public health issue worldwide. Treatments such as surgery, chemotherapy, and radiation therapy often cause psychological and physiological side effects, affecting patients' ability to function and their quality of life (QoL). Physical activity is crucial to cancer rehabilitation, improving physical function and QoL and reducing cancer-related fatigue. However, many patients face barriers to accessing cancer rehabilitation due to socioeconomic factors, transportation issues, and time constraints. Telerehabilitation can potentially overcome these barriers by delivering rehabilitation remotely.

OBJECTIVE:

The aim of the study is to identify how telemedicine is used for the rehabilitation of patients with cancer.

METHODS:

This scoping review followed recognized frameworks. We conducted an electronic literature search on PubMed for studies published between January 2015 and May 2023. Inclusion criteria were studies reporting physical therapy telerehabilitation interventions for patients with cancer, including randomized and nonrandomized controlled trials, feasibility studies, and usability studies. In total, 21 studies met the criteria and were included in the final review.

RESULTS:

Our search yielded 37 papers, with 21 included in the final review. Randomized controlled trials comprised 47% (n=10) of the studies, with feasibility studies at 33% (n=7) and usability studies at 19% (n=4). Sample sizes were typically 50 or fewer participants in 57% (n=12) of the reports. Participants were generally aged 65 years or younger (n=17, 81%), with a balanced gender distribution. Organ-specific cancers were the focus of 66% (n=14) of the papers, while 28% (n=6) included patients who were in the posttreatment period. Web-based systems were the most used technology (n=13, 61%), followed by phone call or SMS text messaging-based systems (n=9, 42%) and mobile apps (n=5, 23%). Exercise programs were mainly home based (n=19, 90%) and included aerobic (n=19, 90%), resistance (n=13, 61%), and flexibility training (n=7, 33%). Outcomes included improvements in functional capacity, cognitive functioning, and QoL (n=10, 47%); reductions in pain and hospital length of stay; and enhancements in fatigue, physical and emotional well-being, and anxiety. Positive effects on feasibility (n=3, 14%), acceptability (n=8, 38%), and cost-effectiveness (n=2, 9%) were also noted. Functional outcomes were frequently assessed (n=19, 71%) with tools like the 6-minute walk test and grip strength tests.

CONCLUSIONS:

Telerehabilitation for patients with cancer is beneficial and feasible, with diverse approaches in study design, technologies, exercises, and outcomes. Future research should focus on developing standardized methodologies, incorporating objective measures, and exploring emerging technologies like virtual reality, wearable or noncontact sensors, and artificial intelligence to optimize telerehabilitation interventions. Addressing these areas can enhance clinical practice and improve outcomes for remote rehabilitation with patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JMIR Cancer Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JMIR Cancer Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Canadá